AJES Pharmaceuticals

What AJES Pharmaceuticals does

AJES Pharmaceuticals is a privately held contract manufacturer operating in the nutraceutical and pharmaceutical research sector, headquartered in Copiague, New York, United States. The company employs between 11 and 50 people and serves as a manufacturing partner for nutraceutical and pharmaceutical products, providing production capabilities to brand owners and other firms that require outsourced manufacturing. The firm's self-described role as a "contract manufacturer" positions it within the broader pharma services value chain, where it would typically handle formulation, production, and packaging under client specifications, though specific product lines, certifications, and capacity details are not disclosed.

The company's primary business model is contract manufacturing services (CMO), generating revenue by producing nutraceutical and pharmaceutical products on behalf of client companies. This B2B model typically involves recurring production runs, long-term supply agreements, and adherence to regulatory quality standards such as cGMP. However, no pricing models, customer segments, specific product offerings, certifications, or partnership arrangements are disclosed in available sources. The company website (ajespharma.com) was inaccessible at the time of data collection, displaying only a bot verification page, which limits primary-source visibility into operational details, leadership, customer base, and strategic positioning.

Data gaps are material: there is no disclosed revenue, no funding history, no named leadership team, no customer logos, no certifications (e.g., FDA registration, cGMP compliance), no patents or trademarks, and no documented strategic actions such as partnerships, acquisitions, or product launches. The only contextual market signal is that the global gummy supplement market is projected to grow at 12.7% CAGR from $30.6B in 2026 to $70.7B by 2033, which may represent an addressable tailwind if AJES participates in gummy nutraceutical manufacturing, though this is not confirmed.

Name

AJES Pharmaceuticals

Website

https://ajespharma.com

Company type

Private

Operating status

Operating

Headcount range

1–10 employees

Short description

AJES Pharmaceuticals is a privately held nutraceutical and pharmaceutical contract manufacturer based in Copiague, New York, employing 11-50 people. It provides outsourced manufacturing services to clients in the nutraceutical and pharmaceutical sectors, though specific products, customers, and certifications are not publicly disclosed.

Ownership category

akta.pro rank

Product category

Contract Pharmaceutical Manufacturing

NAICS

Pharmaceutical Preparation Manufacturing (325412)

SIC

Pharmaceutical Preparations (2834)

akta.pro industry

PRIMARYHLAIABAI

Contract Development & Manufacturing for Generics (CDMO/CMO)

Healthcare & Life Sciences/Pharmaceuticals/Generic Pharmaceuticals

Keywords

• Contract pharmaceutical manufacturing
• Nutraceutical contract manufacturing
• Pharmaceutical research services
• Supplement manufacturing services
• Drug formulation development

Headquarters

HQ city

Copiague

HQ country

United States

HQ region

North America

Markets served

GTM type

B2B

Offering type

Hardware or Manufacturing

Cost components

Personnel, Operations, Supply Chain, Technology or R&D

Core offering

AJES Pharmaceuticals is a contract manufacturer and research provider for the nutraceutical and pharmaceutical industries. The company delivers formulation, research and development, and production services for health and wellness products—including dietary supplements and pharmaceutical preparations—on behalf of brand owners in the health products sector. The firm operates out of Copiague, New York, with 11-50 employees.

Differentiator

Problem solved

Functional benefit

Products and services

• Nutraceutical contract manufacturing Contract manufacturing of nutraceutical products, including dietary supplements and gummy-format supplements, for brand owners in the health and wellness industry. Service is delivered from the company's Copiague, NY facility.
• Pharmaceutical contract manufacturing Contract manufacturing services for pharmaceutical preparations, providing production capacity for pharmaceutical companies that need outsourced manufacturing.
• Pharmaceutical and nutraceutical R&D services Research and development services for pharmaceutical and nutraceutical products, including formulation development and product research, delivered to brand owners and pharmaceutical companies.

Ideal customer profiles1 record

Technology focussed No

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Scale indicators5 records

Direct peers

• Sirio Pharma: Sirio is a global nutraceutical and pharmaceutical contract manufacturer with strong gummy/softgel capabilities, making it the closest functional peer to AJES in the same CDMO format and customer set.
• Procaps Group: Procaps develops and manufactures pharmaceutical and nutraceutical products including gummies and softgels under CDMO and private-label models, closely overlapping with AJES's stated offering.
• Vitakem: Vitakem is a US-based contract nutraceutical manufacturer offering custom formulation and gummy/softgel capabilities — a similarly sized, US-located CDMO directly comparable to AJES.
• Soft Gel Technologies (SGTI): SGTI is a US contract manufacturer specializing in softgel and gummy supplement production for brands, making it a directly comparable format and customer-set peer.

Broad incumbents

• Aenova Group: Aenova is a large European-headquartered CDMO offering solid dosage, softgel, and sterile pharma manufacturing — a broader incumbent competing for the same nutraceutical and pharma brand-owner contracts AJES targets.
• Catalent: Catalent is one of the largest global pharmaceutical CDMOs offering softgel, oral solid, and biologics services, and routinely competes for nutraceutical-adjacent pharma contract manufacturing work.
• Thermo Fisher Scientific (Patheon): Thermo Fisher's Patheon division is a top-tier global pharma CDMO; it competes for higher-end pharma contract manufacturing work that AJES aspires to grow into.

Emerging players

• CapsCanada: CapsCanada provides capsule and liquid-fill contract manufacturing services to nutraceutical brands, overlapping with AJES on the dosage-form and contract-services axis.

Market position

Strengths2 records

Weaknesses3 records

Key risks5 records

Key highlights2 records

Customer concentration

• LinkedInlinkedin.com/company/ajes-pharmaceuticals-llc

Revenue estimate

Valuation estimate

Number of profiles

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about AJES Pharmaceuticals